Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
University of Science and Technology of China, Hefei, 230026, China.
Cell Mol Life Sci. 2021 Mar;78(6):2419-2428. doi: 10.1007/s00018-020-03702-9. Epub 2020 Nov 17.
BCL2L13 is a BCL2-like protein. It has been discovered for two decades, now on the way to be a hotspot of research with its physiological and pathological meanings found in recent years. Start with the pro-apoptotic activity, there have been reported consecutively that BCL2L13 could also induce mitochondrial fragmentation, inhibit cell death and promote mitophagy. Similar to BNIP3, BCL2L13 cannot be indiscriminately categorized into pro- or anti-apoptotic proteins. It anchors in the mitochondrial outer membrane, and expresses in various cells and tissues. This article reviews for the first time that BCL2L13 functions in physiological processes, such as growth and development and energy metabolism, and its dysregulation participating in pathological processes, including cancer, bacterial infection, cardiovascular diseases and degenerative diseases, suggesting its important roles in these events.
BCL2L13 是一种 BCL2 样蛋白。它已经被发现了二十年,近年来其生理和病理意义的发现使其成为研究的热点。从促凋亡活性开始,已经连续报道 BCL2L13 还可以诱导线粒体碎片化,抑制细胞死亡并促进线粒体自噬。与 BNIP3 类似,BCL2L13 不能被随意归类为促凋亡或抗凋亡蛋白。它锚定在线粒体的外膜上,并在各种细胞和组织中表达。本文首次综述了 BCL2L13 在生长发育、能量代谢等生理过程中的功能,以及其在包括癌症、细菌感染、心血管疾病和退行性疾病在内的病理过程中的失调,表明其在这些事件中发挥着重要作用。